810 411

Cited 0 times in

Efficacy of clotinab in acute myocardial infarction trial-ST elevation myocardial infarction (ECLAT-STEMI)

Authors
Kim, JS; Park, SM; Kim, BK; Ko, YG; Choi, D; Hong, MK; Seong, IW; Kim, BO; Gwon, HC; Hong, BK; Tahk, SJ; Park, SW; Kim, CJ; Jeong, MH; Yoon, J; Jang, Y; ECLAT-STEMI Trial investigators
Citation
Circulation journal : official journal of the Japanese Circulation Society, 76(2):405-413, 2012
Journal Title
Circulation journal : official journal of the Japanese Circulation Society
ISSN
1346-98431347-4820
Abstract
BACKGROUND: This study investigated the efficacy and the safety of the upstream glycoprotein (Gp) IIb/IIIa inhibitor (clotinab; ISU ABXIS, Seoul, Republic of Korea) under 600-mg clopidogrel pretreatment compared with provisional use in ST-elevation myocardial infarction (STEMI).



METHODS AND RESULTS: A total of 786 STEMI patients were randomized to upstream use in the emergency room (ER) (n = 392) or provisional use during percutaneous coronary intervention (PCI) (n = 394). All patients were prescribed 600-mg clopidogrel in the ER. The primary endpoint was the 30-day incidence of composite events including death, nonfatal myocardial infarction, target vessel revascularization, and stroke. There was no significant difference in the events that occurred in 40 patients (10.2%) in the upstream arm and 55 patients (14.0%) in the provisional arm during the 30 days (odds ratio 0.70, 95% confidence interval 0.45-1.08). Major bleeding was higher in the upstream arm (1.5% vs. 0%, P = 0.02). However, there was a significant reduction in 30-day composite events in the upstream arm in the high-risk population (Killip class ≥II or GRACE score >140).



CONCLUSIONS: The upstream use of clotinab under a 600-mg clopidogrel loading may not significantly reduce cardiac events following primary PCI but may improve the clinical outcome in high-risk patients.
MeSH terms
Aged*Angioplasty, Balloon, Coronary/statistics & numerical dataAntibodies, Monoclonal/*administration & dosageCombined Modality TherapyCoronary AngiographyElectrocardiographyEmergency Medical Services/methods/statistics & numerical dataFemaleFollow-Up StudiesHumansImmunoglobulin Fab Fragments/*administration & dosageIncidenceKaplan-Meier EstimateMaleMiddle AgedMyocardial Infarction/diagnosis/*drug therapy/mortalityPlatelet Aggregation Inhibitors/*administration & dosageProspective StudiesRisk FactorsTreatment Outcome
PMID
22146757
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Cardiology
AJOU Authors
탁, 승제
Full Text Link
Files in This Item:
22146757.pdfDownload
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse